NSEAcquisition5 Aug 2026 · 5 Aug 2026, 07:58 pm

Acquisition

Aster DM Quality Care Limited · ASTERDM

✦ AI Summaryacquisition

Aster DM Quality Care Limited has informed the Exchange about the acquisition of equity shares of United CIIGMA Institute of Medical Sciences, a subsidiary company of the Company. The acquisition is pursuant to the exercise of put option rights by certain minority shareholders under the Shareholders' Agreement.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aster DM Quality Care Limited has informed the Exchange about Acquisition of equity shares of United CIIGMA Institute of Medical Sciences, a subsidiary company of the Company.

Attachments (1)

📄

ASTERDM2_05082026195812_BM_Outcome-sd.pdf

pdf

Download →
View document text
05 August 2026 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra, India Maharashtra, India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir / Madam, Subject: Outcome of Board Meeting held on 05 August 2026 i. Approval of Notice of Postal Ballot and Notice of 18th Annual General Meeting ii. Termination of the operations and management agreement in respect of Aster G. Madegowda Hospital, Maddur iii. Acquisition of equity shares of United CIIGMA Institute of Medical Sciences, an existing subsidiary company of the Company Ref: Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to our letter dated 30 July 2026 and in accordance with Regulation 30 of the Listing Regulations, we wish to inform you that the Board of Directors of Aster DM Quality Care Limited (formerly known as Aster DM Healthcare Limited) (“the Board” and “the Company”, respectively) at its meeting held today i.e. 5 August 2026, inter alia, has approved: 1. Seeking approval of shareholders for special business through Postal Ballot and Notice of Postal Ballot. The Notice of Postal Ballot will be sent to the shareholders and stock exchanges in due course. 2. Convening 18th Annual General Meeting of the Company on Monday, 28 September 2026, at 11:30 A.M. IST through video conferencing or other audio-video means and the notice thereof. The Notice of 18th Annual General Meeting will be sent to the shareholders and stock exchanges in due course. 3. Termination of the operations and management agreement in respect of Aster G. Madegowda Hospital, Maddur. 4. Acquisition of equity shares of United CIIGMA Institute of Medical Sciences, an existing subsidiary company of the Company, pursuant to the exercise of put option rights by certain minority shareholders under the Shareholders' Agreement. The relevant details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided as Annexure I and II respectively. Aster DM Q uality Care Limited (Formerly Aste r DM Healthcare Ltd.) Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383 Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833 E-mail: cs@asterqualitycare.com Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com #42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1, Yeshwanthpur, Bengaluru-560022 The Meeting of the Board of Directors commenced at 02:30 PM (IST) and concluded at 04:40 PM (IST). The above information will also be hosted on the website of the Company i.e. www.asterqualitycare.com Kindly take the above on records. Thank you, Yours faithfully, For Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Hemish Purushottam Company Secretary and Compliance Officer M. No: A24331 Aster DM Q uality Care Limited (Formerly Aste r DM Healthcare Ltd.) Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383 Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833 E-mail: cs@asterqualitycare.com Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com #42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1, Yeshwanthpur, Bengaluru-560022 Annexure I Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master Circular S. No Particulars Details 1 date of such binding agreement, if 1 April 2023 any, entered for sale of such unit/division, if any 2 amount & percentage of turnover 0.15% of the revenue for the entity during the last or revenue or income and net f inancial year worth of the listed entity contributed by such unit or division during the last financial year; 3 date of closure or estimated time 5 August 2026 of closure; (or such effective date as may be finalized between the parties) 4 reasons for closure The hospital has not achieved the anticipated operational scale and profitability and has incurred sustained operating losses since commencement of operations. Accordingly, following a strategic review, the Company has decided to discontinue the arrangement and exit the facility. Aster DM Q uality Care Limited (Formerly Aste r DM Healthcare Ltd.) Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383 Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833 E-mail: cs@asterqualitycare.com Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com #42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1, Yeshwanthpur, Bengaluru-560022 Annexure II Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master Circular S. No Particulars Details 1 Name of the target entity, details in brief Name: United CIIGMA Institute of Medical such as size, turnover etc. Sciences Private Limited (“UCIMSPL”) Date of incorporation: 7 February 2011 Authorized Share Capital: Rs. 52,00,00,000/- (Rupees Fifty-Two Crore Only) comprising 5,20,00,000 equity shares of face value of Rs. 10/- each. Paid-up Share Capital: Rs. 51,36,67,110/- (Rupees Fifty-one crore thirty-six lakhs sixty-seven thousand one hundred and ten Only) comprising 5,13,66,711 equity shares of face value of Rs.10/- each. Turnover: For the financial year ended 31 March 2026: Rs 153.64 crores. 2 Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter The transaction is done at an arm’s length basis. group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” Aster DM Quality Care Limited (Formerly Aster DM Healthcare Ltd.) Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev CIN: L85110TS2008PLC207383 Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Telephone: +91 96060 61833 E-mail: cs@asterqualitycare.com Corporate Office: Brigade Deccan Heights 20th & 12th Floor, Website: www.asterqualitycare.com #42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1, Yeshwanthpur, Bengaluru-560022 S. No Particulars Details 3 Industry to which the entity being Healthcare Industry acquired belongs 4 Objects and impact of acquisition Acquisition of up to an additional 12% equity stake in (including but not limited to, disclosure of United CIIGMA Institute of Medical Sciences Private reasons for acquisition of target entity, if Limited (UCIMSPL) through exercise of the put option its business is outside the main line of by the Promoter/Promoter Group of UCIMSPL, in business of the listed entity) accordance with the Shareholders' Agreement dated June 10, 2022. UCIMSPL will continue to be the Acquirer’s Subsidiary. 5 Brief details of any governmental or Not Applicable regulatory approvals required for the acquisition; 6 Indicative time period for completion of Within the next 1–2 months the acquisition; 7 Consideration - whether cash Cash consideration consideration or share swap or any other form and details of the same; 8 Cost of acquisition and/or the price at Up to Rs. 40.93 crores which the shares are acquired; 9 Percentage of shareholding / control Up to 12% acquired and / or number of shares acquired; 10 Brief background about the entity UCIMSPL is headquartered in Chhatrapati acquired in terms of products/line of Sambhajinagar and was incorporated on 7 February business acquired, date of incorporation, 2011. history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in The company is primarily engaged [Showing first 8,000 characters — download PDF for full document]